La Jolla Pharmaceutical (LJPC) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    La Jolla Pharmaceutical

    NASDAQ: LJPC · Real-Time Price · USD
    6.19
    -0.02 (-0.32%)
    At close: Aug 15, 2022, 10:00 PM

    La Jolla Pharmaceutical Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2021
    Period Ending Dec 31, 2021
    Revenue
    		 75.72M
    Cost of Revenue
    		 13.49M
    Gross Profit
    		 62.23M
    Operating Income
    		 21.83M
    Interest Income
    		 7K
    Pretax Income
    		 19.71M
    Net Income
    		 19.66M
    Selling & General & Admin
    		 35.39M
    Research & Development
    		 5.01M
    Other Expenses
    		 n/a
    Operating Expenses
    		 40.4M
    Interest Expense
    		 10.46M
    Selling & Marketing Expenses
    		 5.62M
    Cost & Expenses
    		 53.89M
    Income Tax Expense
    		 49K
    Shares Outstanding (Basic)
    		 34.18M
    Shares Outstanding (Diluted)
    		 34.18M
    EPS (Basic)
    		 0.58
    EPS (Diluted)
    		 0.58
    EBITDA
    		 32.05M
    EBIT
    		 30.17M
    Depreciation & Amortization
    		 1.88M

    Add to Watchlist